Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
Enregistré dans:
Auteurs principaux: | David S. Fedson, Steven M. Opal, Ole Martin Rordam |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2de20c1915d94e49bc96f183bdb1699e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
par: O. K. Vikulova, et autres
Publié: (2020) -
Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
par: M. O.E. Irhuma, et autres
Publié: (2016) -
2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications
par: Luigi Cappannoli, et autres
Publié: (2020) -
Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study
par: Puspita FM, et autres
Publié: (2021) -
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
par: Zhang C, et autres
Publié: (2021)